Use of oral contraceptives in the treatment of women with polycystic ovary syndrome

By Stovall Dale W   Menke Marie   Springel Edward   Jarvis Amber   Karjane Nicole  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 3, 2007-05 ,pp. : 347-355

Informa Healthcare

Access to resources Recommend Favorite

Use of an oral contraceptive containing drospirenone in an extended regimen

By Sillem M.   Schneidereit R.   Heithecker R.   Mueck A. O.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 3, 2003-09 ,pp. : 162-169

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen

By Mansour Diana   Verhoeven Carole   Sommer Werner   Weisberg Edith   Taneepanichskul Surasak   Melis Gian Benedetto   Sundström-Poromaa Inger   Korver Tjeerd  

The European Journal of Contraception and Reproductive Health Care, Vol. 16, Iss. 6, 2011-12 ,pp. : 430-443

Informa Healthcare

Access to resources Recommend Favorite

The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive

By Zimmerman Yvette   Coelingh Bennink Herjan J. T.   Wouters Wout   Ebes Frieda   Fauser Bart C. J. M.  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 6, 2013-12 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of combined ethinyloestradiol (0.035 mg) and cyproterone acetate (2 mg) in acne and hirsutism in women with polycystic ovary syndrome

By Falsetti L.   Ramazzotto Francesca   Rosina Barbara  

Journal of Obstetrics & Gynaecology, Vol. 17, Iss. 6, 1997-12 ,pp. : 565-568

Informa Healthcare

Access to resources Recommend Favorite